Hai Robotics HKEX IPO filing lapses; global ACR solutions market share exceeds 30%
NewTimeSpace News: Shenzhen Hai Robotics Innovation Intelligent Technology Group Co., Ltd. submitted its listing application to HKEX on 13 February 2026, which has lapsed after six months. Goldman Sachs and CITIC Securities acted as the original joint sponsors.
The Company is a global leader in warehouse automation, focusing on picking automation and pioneering the integrated ACR solution. According to CIC (China Insights Consultancy), in 2024 the Company was the world's largest ACR solution provider, with a market share of over 30% by both revenue and shipment volume. In 2025, it launched HaiPick Climb, the world's first one-sided climbing ACR solution to achieve large-scale commercial deployment, supporting storage heights of up to 15 metres.
The Company provides tailor-made ACR solutions for two core application areas: circulation and manufacturing. Its business footprint covers more than 40 countries and regions, including mainland China, the Americas, EMEA, Japan and other Asia-Pacific regions. For the nine months ended 30 September 2025, orders from markets outside mainland China accounted for over 50% of total orders, contributing 39.6% of revenue.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Hai Robotics: Publishes application proof, 2025 revenue RMB 2,016.9 million and world's largest ACR solution provider by revenue and shipments
- HAI ROBOTICS Receives Supplementary Material Requirements for Overseas Listing Filing, Focusing on Compliance of Unevaluated Capital Increase & Impact of Work Safety Penalties
- Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
- Korean Stocks Open Higher but Close Lower as Semiconductor Heavyweights Slip; Csop Kospi 200 Etf (03121.HK) Falls 1.30%
- AOM INT'L (00381.HK): Launches Twelve Dynasties Wine Project Combining Cultural Export and Digital Assets